We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $398M
1-Year Est. Return 22.87%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$109M
AUM Growth
+$4.36M
Cap. Flow
+$2.81M
Cap. Flow %
2.59%
Top 10 Hldgs %
32.72%
Holding
118
New
7
Increased
35
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$1.42M
2
TLP
Transmontaigne
TLP
+$489K
3
TGT icon
Target
TGT
+$242K
4
CB icon
Chubb
CB
+$231K
5
GCP
GCP Applied Technologies Inc.
GCP
+$220K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$876K
2
CB
CHUBB CORPORATION
CB
+$438K
3
WPZ
Williams Partners L.P.
WPZ
+$285K
4
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$243K
5
ETP
Energy Transfer Partners L.p.
ETP
+$212K

Sector Composition

Rank Sector Weight
1 Healthcare 24.38%
2 Energy 14.74%
3 Technology 11.13%
4 Industrials 9.8%
5 Consumer Staples 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROK icon
26
Rockwell Automation
ROK
$52.2B
$1.38M 1.27%
12,120
– –
GILD icon
27
Gilead Sciences
GILD
$169B
$1.37M 1.26%
14,570
+220
+2% +$19.8K
BA icon
28
Boeing
BA
$169B
$1.32M 1.21%
10,380
– –
BAX icon
29
Baxter International
BAX
$12.1B
$1.32M 1.21%
31,600
– –
SWK icon
30
Stanley Black & Decker
SWK
$14.2B
$1.32M 1.21%
12,350
– –
BXLT
31
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$1.31M 1.21%
32,100
– –
NOC icon
32
Northrop Grumman
NOC
$73.7B
$1.26M 1.16%
6,288
+50
+0.8% +$9.44K
ADP icon
33
Automatic Data Processing
ADP
$103B
$1.25M 1.15%
13,850
+550
+4% +$46.1K
CL icon
34
Colgate-Palmolive
CL
$75.3B
$1.21M 1.11%
17,000
– –
DD icon
35
DuPont de Nemours
DD
$18.1B
$1.19M 1.1%
9,189
– –
SNY icon
36
Sanofi
SNY
$106B
$1.17M 1.08%
28,950
-200
-0.7% -$8.04K
DD
37
DELISTED
Du Pont De Nemours E I
DD
$1.09M 1%
17,028
– –
GE icon
38
GE Aerospace
GE
$361B
$1.08M 0.99%
7,058
+328
+5% +$46.3K
PFE icon
39
Pfizer
PFE
$143B
$1.06M 0.97%
37,048
+2,761
+8% +$78.9K
AZN icon
40
AstraZeneca
AZN
$263B
$1.05M 0.97%
18,650
-1,000
-5% -$60.1K
AGO icon
41
Assured Guaranty
AGO
$3.73B
$1.03M 0.95%
40,300
-500
-1% -$12.3K
FMS icon
42
Fresenius Medical Care
FMS
$12.9B
$1.02M 0.94%
23,288
– –
HES
43
DELISTED
Hess
HES
$937K 0.86%
18,009
– –
GRA
44
DELISTED
W.R. Grace & Co.
GRA
$907K 0.84%
12,100
– –
AEP icon
45
American Electric Power
AEP
$72.4B
$883K 0.81%
13,176
– –
ABBV icon
46
AbbVie
ABBV
$449B
$740K 0.68%
12,893
+250
+2% +$13.9K
SLB icon
47
SLB Ltd
SLB
$70.4B
$721K 0.66%
10,000
– –
CVX icon
48
Chevron
CVX
$366B
$682K 0.63%
7,240
+300
+4% +$26.2K
HD icon
49
Home Depot
HD
$347B
$677K 0.62%
5,023
+550
+12% +$68.5K
F icon
50
Ford
F
$56.5B
$659K 0.61%
50,300
– –
1
2
3 4 5

Similar funds

CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
LSA
Lansing Street Advisors Ambler, Pennsylvania $397M AUM 18.7% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return

Searle & Co's Q1 2016 Portfolio in Review

As of Q1 2016, Searle & Co held 118 positions worth $109M, up 4.2% from $104M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Searle & Co's Q1 2016 filing shows 7 new, 35 increased, 4 reduced and 7 closed positions. Its largest new stake was Palo Alto Networks: 57,600 shares worth $1.55M. The largest sale was Berkshire Hathaway Class B, an estimated $876K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Energy and Technology.

  • Searle & Co's largest Q1 2016 buy was Palo Alto Networks: 57,600 shares worth $1.55M.
  • Searle & Co added most to Progenics Pharmaceuticals Inc in Q1 2016, an estimated $200K increase.
  • Searle & Co's biggest Q1 2016 reduction was AstraZeneca, cutting an estimated $60.1K.
  • Searle & Co fully exited Berkshire Hathaway Class B in Q1 2016, selling an estimated $876K.
  • Searle & Co's ten largest holdings make up 33% of its $109M portfolio in Q1 2016.
  • Searle & Co opened 7 new positions and closed 7 in Q1 2016.
  • Searle & Co's portfolio value rose 4.2% quarter-over-quarter to $109M.

Based on Searle & Co's 13F filing for Q1 2016, filed 12 Apr 2016.